Abstract 5399: Myocardial Contractile Dysfunction is Associated with Fetal Cardiac Bypass in a Sheep Model

Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Jodie Y Duffy ◽  
R. Scott Baker ◽  
Mitali Basu ◽  
Casey Reed ◽  
Emily A Heeb ◽  
...  

Declining cardiac output and placental dysfunction are the key barriers to successful fetal cardiac bypass for in utero repair of congenital heart defects. Identifying myocardial dysfunction, especially in the RV that is considered the systemic ventricle in fetal life, may be important for success. We hypothesized that fetal cardiac bypass results in myocardial contractile dysfunction that reduces cardiac output and placental perfusion, leading to placental dysfunction and fetal demise. Three fetuses from mid-term pregnant ewes were subjected to 30 min of cardiac bypass and followed for 120 min after bypass. Piezoelectric crystals (Sonometrics, Ontario, CA) were placed on three axes of the fetal heart and pressure catheters (Millar Instruments, Houston, TX) were inserted in the left and right ventricle (RV). Data were analyzed by repeated measures ANOVA with Fisher’s PLSD post hoc analyses. Representative RV pressure-volume loops in the figure showed that preload increased after bypass, indicated by increased end-diastolic volume (mean 4.1±.7 vs. 4.4±1 mL) and pressure (mean 14.3 ±7 vs. 31.3± 3 mmHg, P<.05). RV contractility decreased after bypass: pre-bypass dPdt max (mmHg/sec) - 880±93 vs. 731±102 at 120 min after bypass (P≤.1) and dP/dt min - 798±4 vs. 689±11 (P≤.1). Preload recruitable stroke work (slope of regression line) also decreased from 28.5±7 pre-bypass to 22.1±5 at 120 min post-bypass. Increased RV preload and RV contractile dysfunction are evident after fetal cardiac bypass. Minimizing the associated myocardial dysfunction is important for the success of fetal surgery to repair complex congenital heart defects. This research has received full or partial funding support from the American Heart Association, AHA National Center.

2009 ◽  
Vol 26 (5) ◽  
pp. 412-415 ◽  
Author(s):  
Maren Tomaske ◽  
Walter Knirsch ◽  
Oliver Kretschmar ◽  
Christian Balmer ◽  
Katja Woitzek ◽  
...  

1988 ◽  
Vol 32 (1) ◽  
pp. 39
Author(s):  
B. A. KEAGY ◽  
B. R. WILCOX ◽  
C. L. LUCAS ◽  
H. S. HSIAO ◽  
G. W. HENRY ◽  
...  

1988 ◽  
Vol 61 (8) ◽  
pp. 612-616 ◽  
Author(s):  
Daniel S. Miles ◽  
Robert W. Gotshall ◽  
Jane C. Golden ◽  
Dwight T. Tuuri ◽  
Robert H. Beekman ◽  
...  

1987 ◽  
Vol 93 (5) ◽  
pp. 658-664 ◽  
Author(s):  
Blair A. Keagy ◽  
Benson R. Wilcox ◽  
Carol L. Lucas ◽  
Henry S. Hsiao ◽  
G. William Henry ◽  
...  

2019 ◽  
Vol 72 (7) ◽  
pp. 1281-1287
Author(s):  
Veronika Dudnyk ◽  
Olha Zborovska ◽  
Yuilia Vyzhga ◽  
Kateryna Khromykh ◽  
Ganna Zvenigorodska ◽  
...  

Introduction: Speed myocardial indicators and estimation of galectin-3 presented for estimation of myocardial dysfunction in children with congenital heart defects (CHD). The aim: Evaluate myocardial function while using tissue Doppler imaging (TDI) and galectin-3 in children with CHD after surgical correction. Materials and methods: We examined 184 children. The study assessed both ventricle systolic and diastolic performance by TDI in combination with tricuspid annular plane systolic excursion (TAPSE). Additionally, systolic (S') and diastolic (ratio E/E') TDI measurements were obtained at the lateral part of mitral annular, interventricular part, and lateral part of tricuspid valve (S`ma lateral, S` ma septal, S`ta lateral та E/E' malateral, E/E' maseptal, E/E' talateral). Galectin-3 amount in serum was detected by immune enzyme method by kit «HumanGalectin-3». Results: Compared to results of the healthy children systolic TDI measurements in patients with CHD were significantly lower: S` ma lateral 7,81±0,10 сm/s vs 9,85±0,28 сm/s, S` ta lateral 9,70±0,12 сm/s vs 12,8±0,17 сm/s and TAPSE, 1,48±0,02 vs 2,14±0,03 сm/s (р<0,01). Ratio E/E' in patients with CHD were different from results of the healthy children in all myocardial segments: E/Е` ma lateral 7,45±0,21 vs 6,17±0,12, E/Е` ma septal 9,17±0,22 vs 7,54±0,13, E/Е` ta lateral 6,42 ± 0,14 vs 4,64±0,12, (р<0,05). Patients with CHD got galectin-3 content in serum 7,04±0,21 ng/ml vs 4,17±0,17 ng/ml (р<0,01) results of the healthy children. Conclusions: Analyze of TDI measurements and galectin-3 content allows evaluate myocardial dysfunction in asymptomatic patients with CHD after surgical correction.


2003 ◽  
Vol 22 (4) ◽  
pp. 61-63 ◽  
Author(s):  
Susan Givens Bell

MANY NEONATES WHO UNDERGO SURGICAL REPAIR FOR congenital heart defects are at high risk for developing low cardiac output syndrome following surgery.1 A variety of causes contributes to diminished cardiac output. Four major factors are (1) age less than one month, (2) weight less than 2.5 kg, (3) preoperative condition, and (4) complexity of the heart defect.2


2004 ◽  
Vol 4 (3) ◽  
pp. 194-207 ◽  
Author(s):  
A Galindo ◽  
F Gutiérrez-Larraya ◽  
P de la Fuente

Sign in / Sign up

Export Citation Format

Share Document